Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Send us all your questions or requests, and our expert team will assist you.
Treating systemic nephrology conditions requires a two-pronged strategy. First, doctors must treat the underlying systemic disease—the fire that is burning throughout the body. Second, they must support and protect the kidneys from further damage while the body heals. This often involves powerful medications that calm the immune system or control metabolic imbalances.
The treatment plan is highly personalized. It depends on the specific diagnosis, the severity of the organ damage, and the patient’s overall health. It is rarely a quick remedy; rather, it is a long-term management plan that moves through phases: induction (getting the disease under control) and maintenance (keeping it quiet). Follow-up is intensive and lifelong, requiring a strong partnership between the patient and the medical team.
For autoimmune diseases like lupus nephritis and vasculitis, the cornerstone of treatment is immunosuppression. The goal is to stop the immune system from attacking the kidneys.
This usually starts with corticosteroids (like prednisone). Steroids act as a massive fire extinguisher, reducing inflammation quickly. However, because steroids have significant side effects when used long-term, doctors also start “steroid-sparing” agents. These include chemotherapy-type drugs like cyclophosphamide or mycophenolate mofetil. These drugs work by inhibiting the reproduction of the immune cells that are launching the attack. In recent years, biologic drugs (like rituximab) have become game-changers. These are engineered antibodies that target and remove specific B-cells, the factories that produce the harmful antibodies.
Suppressing the immune system comes with risks, primarily infection. Patients need to be monitored closely for signs of illness. Preventive antibiotics may be prescribed to ward off pneumonia. Regular blood tests check white blood cell counts to ensure the immune system isn’t suppressed too heavily. Balancing the risk of infection against the risk of kidney failure is the central challenge of this therapy.
Controlling blood pressure is critical for all kidney patients, but especially for those with systemic disease. High blood pressure acts as a mechanical stressor that accelerates kidney scarring.
The preferred medications are ACE inhibitors (like lisinopril) or ARBs (like losartan). These drugs do double duty. They lower systemic blood pressure, but they also specifically relax the blood vessels inside the kidney’s filters. This reduces the internal pressure within the kidney, decreasing protein leakage and protecting the delicate tissue from further mechanical injury.
For diabetic nephropathy, the focus is on strict blood sugar control. High blood sugar levels can act as sharp objects in the kidney’s vessels.
Newer classes of diabetes medications, such as SGLT2 inhibitors and GLP-1 agonists, have revolutionized kidney care. These drugs lower blood sugar and have direct protective effects on the heart and kidneys. They have been proven to slow the progression of kidney disease significantly. Doctors also use continuous glucose monitors to help patients keep their sugar levels in a safe range, preventing the spikes that cause the most damage.
The goal is not just to lower A1C levels but to do so safely without causing low blood sugar (hypoglycemia). By managing diabetes aggressively, doctors can often halt the progression of kidney damage, keeping patients off dialysis for years or even decades.
In severe, acute cases of vasculitis or certain antibody-mediated diseases, medications might take too long to work. The blood is so full of toxic antibodies that they need to be physically removed.
Plasmapheresis is a procedure that cleans the blood. The patient’s blood is run through a machine that separates the plasma (the liquid part containing the antibodies) from the cells. The “dirty” plasma is discarded and replaced with clean plasma or albumin. This mechanical removal of antibodies acts as a bridge, buying time for the immunosuppressive drugs to kick in and stop new antibody production.
Sometimes, despite the best treatment, the kidneys fail. In acute flares, the kidneys might shut down temporarily.
Dialysis serves as a bridge in these situations. It takes over the work of cleaning the blood, giving the inflamed kidneys a rest. For many patients with acute vasculitis or lupus flares, kidney function can recover after a few months of treatment, and they can come off dialysis. However, if the scarring is too extensive, dialysis may become a long-term necessity or a bridge to a kidney transplant. Even on dialysis, treating the systemic disease remains important to protect other organs like the heart and lungs.
Once the acute phase is over, the disease enters the maintenance phase. This involves regular checkups, usually every 3 to 6 months.
Doctors monitor for “flares”—a return of the disease activity. They track protein levels in the urine and creatinine in the blood. They also monitor for long-term side effects of treatment, such as bone thinning from steroids or heart risks from diabetes. This care is collaborative. The nephrologist communicates with the rheumatologist and primary care doctor to ensure vaccinations are up to date and cardiovascular health is optimized.
Send us all your questions or requests, and our expert team will assist you.
Usually no. Doctors try to taper the dose down as quickly as possible once the disease is under control to minimize side effects.
In cases of acute systemic diseases, the answer is indeed yes. If the inflammation is treated quickly, kidneys can often heal enough to get off dialysis. Scarring, however, is permanent.
Common side effects include nausea, fatigue, hair thinning, and increased risk of infection. Your doctor will prescribe you meds to help with nausea and monitor your blood counts.
Remission means there are no signs of active disease—no protein in the urine, stable kidney function, and no systemic symptoms like rash or joint pain.
Yes. However, doctors usually wait until the lupus has been quiet (in remission) for at least 6 months to ensure the new kidney isn’t attacked immediately.
